Quoin Pharmaceuticals Ltd. Adjustments to Additional Paid in Capital, Warrant Issued
Quoin Pharmaceuticals Ltd. (QNRX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $296.36 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-14.
Discontinued › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2024-03-14
- Quoin Pharmaceuticals Ltd. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-03-31 was $296.36K.
- Quoin Pharmaceuticals Ltd. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $296.36K, a 97.61% decline from fiscal 2021.
- Quoin Pharmaceuticals Ltd. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $12.41M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2022-12-31 | $296.36K 10-K · filed 2024-03-14 | |
| 2022-03-31 | $296.36K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $12.41M 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 |